| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0066 | 1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.0091 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.0039 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |